[{"from": "human", "value": "Provide a brief overview of this molecule. [C][C][C@H1][Branch2][Ring1][=Branch1][N][C][C@@H1][Ring1][=Branch1][N][Branch1][Branch1][C][Ring1][Branch1][=O][O][S][=Branch1][C][=O][=Branch1][C][=O][O][C][=Branch1][C][=O][N][C][C][C][N][C][C][Ring1][=Branch1]"}, {"from": "gpt", "value": "The molecule is a diazabicyclooctane beta-lactamase inhibitor, similar in structure to [avibactam]. It includes a piperidine ring which reduces export from bacterial cells by producing a positive charge. It is currently available in a combination product which includes [imipenem] and [cilastatin] to treat complicated urinary tract infections (UTIs), pyelonephritis, and complicated intra-abdominal infections in adults. It is considered to be a last-line treatment option and gained FDA approval as part of the combination product Recarbrio\u24c7 in July 2019."}]